Group 1 - The controlling shareholder of Dalian Baiao Chemical Co., Ltd., Dalian Tongyun Investment Co., Ltd., holds a total of 211,581,520 shares, accounting for 29.96% of the company's total share capital [2] - As of the announcement date, Tongyun Investment has pledged a total of 43,000,000 shares, which represents 20.32% of its total holdings and 6.09% of the company's total share capital [2] - The recent pledge involves 15,000,000 shares registered as collateral for a loan to Yantai Huazhou Investment Center (Limited Partnership), with the main debt due date set for March 7, 2026 [3] Group 2 - The company has disclosed that the pledged shares are not used as collateral for major asset restructuring or performance compensation [5] - The company will continue to monitor the pledge and unpledge status of shares held by shareholders and will comply with relevant regulations for timely information disclosure [6]

Core Viewpoint - Baiao Chemical announced that its controlling shareholder, Dalian Tongyun Investment Co., Ltd., has pledged 15,000,000 shares to Yantai Huazhou Investment Center (Limited Partnership), representing 7.09% of the shares held by the shareholder and 2.12% of the company's total share capital [2] Summary by Category - **Pledge Details** - The pledged shares amount to 15,000,000 [2] - This represents 7.09% of the shares held by the controlling shareholder [2] - The pledged shares account for 2.12% of the company's total share capital [2] - **Use of Funds** - The funds from the pledge will be used for the company's own production and operations [2]

Group 1 - The controlling shareholder of Baiao Chemical, Dalian Tongyun Investment Co., Ltd., holds approximately 212 million shares, accounting for 29.96% of the total share capital of the company [1] - As of the announcement date, Tongyun Investment has pledged 43 million shares, which represents 20.32% of its total holdings and 6.09% of the company's total share capital [1] - For the first half of 2025, Baiao Chemical's revenue composition is as follows: 55.19% from the chemical raw materials and chemical products manufacturing sector, and 44.81% from the semiconductor business [1] Group 2 - Baiao Chemical's market capitalization is currently 17.4 billion yuan [1]

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示 大连百傲化学股份有限公司（以下简称"公司"）控股股东大连通运投 资有限公司（以下简称"通运投资"）持有公司股份总数为 211,581,520 股，占 公司总股本的 29.96%。截至本公告日，通运投资累计质押的公司股份数为 43,000,000 股，占其持有公司股份总数的 20.32%，占公司总股本的 6.09%。 一、本次股份质押情况 证券代码：603360 证券简称：百傲化学 公告编号：2025-070 大连百傲化学股份有限公司 关于控股股东股份质押的公告 | 股东名称 | 是否为 控股股 | 本次质押股 数 | 是否 为限 | 是否 补充 | 质押起 始日 | 质押到期日 | 质权人 | 占其所 持股份 | 占公司 总股本 | 质押融资 资金用途 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 东 | | 售股 | 质押 | | | | 比例 | 比例 | | ...

Core Viewpoint - The company Baiao Chemical announced that its controlling shareholder, Tongyun Investment, has pledged 15 million shares, which represents 7.09% of its total shares held and 2.12% of the company's total share capital [1] Summary by Relevant Sections - **Pledge Details** - The pledge of 15 million shares has a start date of September 9, 2025, and will remain in effect until the pledge release registration procedures are completed [1] - **Purpose of Financing** - The funds raised from the pledge will be used for the company's own production and operations [1]

Group 1 - The core viewpoint of the news is that Baiao Chemical's stock price increased by 5.04% to 25.83 CNY per share, with a trading volume of 218 million CNY and a turnover rate of 1.23%, resulting in a total market capitalization of 18.242 billion CNY [1] - Baiao Chemical, established on September 22, 2003, and listed on February 6, 2017, is primarily engaged in the research, production, and sales of isothiazolinone-based industrial biocides [1] - The company's revenue composition shows that domestic business accounts for 66.61%, while overseas business constitutes 33.39% [1] Group 2 - Among Baiao Chemical's top ten circulating shareholders, a fund under Southern Fund, the Southern CSI 1000 ETF (512100), entered the top ten in the second quarter, holding 3.2711 million shares, which is 0.46% of the circulating shares [2] - The Southern CSI 1000 ETF (512100) was established on September 29, 2016, with a latest scale of 64.953 billion CNY, and has achieved a year-to-date return of 22.9% [2] - The fund manager, Cui Lei, has a tenure of 6 years and 307 days, with the fund's total asset scale at 94.976 billion CNY, achieving a best return of 137.42% and a worst return of -17.29% during the tenure [2]

大连百傲化学股份有限公司 2025 年第一次临时股东大会会议资料 大连百傲化学股份有限公司 2025 年第一次临时股东大会会议资料 （603360） 2025 年 09 月 1 | 2025 | 年第一次临时股东大会须知 3 | | --- | --- | | 2025 | 年第一次临时股东大会议程 5 | | 议案 | 1：关于取消监事会、变更注册资本并修订《公司章程》及其附件的议案.7 | | 议案 | 2：关于修订公司管理制度的议案 9 | | 议案 | 3：关于补选公司第五届董事会非独立董事的议案 10 | 2 大连百傲化学股份有限公司 2025 年第一次临时股东大会会议资料 大连百傲化学股份有限公司 2025 年第一次临时股东大会须知 为维护股东的合法权益，保障股东在大连百傲化学股份有限公司（以下简称 "公司"）2025 年第一次临时股东大会会议期间依法行使权利，确保股东大会的 正常秩序和议事效率，根据《中华人民共和国公司法》（以下简称"《公司法》"）、 《上市公司股东会规则》《大连百傲化学股份有限公司章程》（以下简称"《公司 章程》"）等有关规定，制定本须知。 一、各股东请按照本次股东大会会议通知 ...

Core Viewpoint - The company emphasizes that sustainable and stable shareholder returns are built on high-quality and sustainable development, focusing on core business, optimizing management, and enhancing profitability [1] Group 1: Company Overview - Dalian Bai'ao Chemical Co., Ltd. specializes in the research, production, and sales of isothiazolinone industrial biocide raw materials and has been in the industry for over 20 years, becoming the largest producer of such biocides in Asia [1] - In 2024, the company transitioned into the semiconductor equipment sector through its controlling stake in Suzhou Xinhuilian Semiconductor Technology Co., Ltd. and a stake in Xinhuilian New (Suzhou) Technology Co., Ltd., establishing a dual business model of industrial biocides and semiconductor equipment [1] Group 2: Financial Performance - In the first half of the year, the company reported revenue of 749 million yuan, a year-on-year increase of 28.42%, while net profit attributable to shareholders decreased by 44.22% to 91.79 million yuan [2] - The chemical business faced challenges due to external environmental factors, weak market demand, and continuously low prices, leading to sustained pressure on profitability [2] Group 3: Business Segments - The company’s industrial biocide products are primarily exported to Asia, Europe, the United States, and South America, with overall changes remaining stable [2] - Despite the pressure on profitability in the biocide segment, there are positive signs, such as a 7.69% increase in average sales prices of biocide products in the second quarter and a 21.37% decrease in the comprehensive procurement costs of key raw materials [2] - The semiconductor equipment business, led by the subsidiary Xinhuilian, remains a core strategic direction, focusing on technology development, market expansion, and operational stability [3]

Core Viewpoint - Baiao Chemical's stock has shown significant volatility, with a year-to-date increase of 57.66% but a recent decline of 7.48% over the past five trading days [2] Group 1: Stock Performance - As of September 5, Baiao Chemical's stock price was 24.38 CNY per share, with a market capitalization of 17.218 billion CNY [1] - The stock has experienced a 20.40% increase over the past 20 days and a 19.51% increase over the past 60 days [2] - The company has appeared on the stock market's "龙虎榜" three times this year, with the latest appearance on August 28 [2] Group 2: Financial Performance - For the first half of 2025, Baiao Chemical reported a revenue of 749 million CNY, representing a year-on-year growth of 28.42% [2] - The net profit attributable to shareholders was 91.7885 million CNY, which reflects a year-on-year decrease of 44.22% [2] Group 3: Shareholder Information - As of June 30, 2025, Baiao Chemical had 21,300 shareholders, an increase of 20.58% from the previous period [2] - The average number of circulating shares per shareholder was 33,173, up by 16.11% [2] - The company has distributed a total of 1.224 billion CNY in dividends since its A-share listing, with 722 million CNY distributed over the past three years [3] Group 4: Business Overview - Baiao Chemical, established on September 22, 2003, specializes in the research, production, and sales of isothiazolinone-based industrial biocides [2] - The company's revenue composition is 66.61% from domestic business and 33.39% from international business [2] - Baiao Chemical is classified under the basic chemical industry, specifically in agricultural chemical products [2]

Core Viewpoint - The company Baiao Chemical announced a share buyback plan, indicating a strategic move to enhance shareholder value and confidence in the company's future performance [2] Summary by Categories Company Actions - As of September 4, 2025, the company has repurchased a total of 5,365,500 shares through a centralized bidding process [2] - The repurchased shares represent 0.76% of the company's total share capital [2]